Much of the poor mental health during school closures tied to established risk factors
Racial/Ethnic Disparities Persist in Adult Vaccination Coverage
Socioeconomic differences in flu vaccine uptake narrowed for those aged 18 to 64 years, but racial/ethnic, SES differences persisted for ≥65s
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate second dose
Sickle Cell Disease May Up Risk for Poor COVID-19 Outcomes
Sickle cell trait also associated with increased risk for COVID-19-related hospitalization and death, but to a lesser extent
Cognitive Impairment Reported After COVID-19 Infection
Cognitive impairment identified in cohort of older Amerindians and in 32 patients after mild-to-moderate COVID-19
CDC Now Says Vaccinated Should Be Tested After COVID-19 Exposure, Even Without Symptoms
Even though fully vaccinated people may still get infected, infections tend to have mild or no symptoms
Mississippi Health System Buckles Under ‘Astounding’ Rise in COVID-19 Cases
Compared with the first half of July, the number of infections more than doubled in the past two weeks and deaths rose by 51 percent
How Fast Do COVID-19 Vaccines Wane?
The University College London (UCL) stated in a press release, ‘total antibody levels generated by COVID-19 vaccines appear to start declining from as early as six weeks after complete vaccination.’
‘And antibodies can be reduced by more than 50% over ten weeks, according to new data from UCL’s Virus Watch study.’
Do COVID-19 Vaccines Wane?
The University College London (UCL) stated in a press release, ‘total antibody levels generated by COVID-19 vaccines appear to start declining from as early as six weeks after complete vaccination.’ The median age of the people was 86, and the study is about a single vaccine dose of an English vaccine that is normally two doses.
‘And antibodies can be reduced by more than 50% over ten weeks, according to new data from UCL’s Virus Watch study.’
Third COVID-19 Vaccine Dose May Prompt Response in Transplant Recipients
Third dose of mRNA-1273 vaccine induces serologic response in 49 percent of kidney recipients who did not respond after two doses